This content is machine translated Pulmonary sarcoidosis Prednisone vs. MTX: a draw after 24 weeks Pulmonary sarcoidosis remains a persistent clinical challenge in respiratory medicine. Although glucocorticoids have long been the mainstay of first-line therapy, their side effects often complicate long-term treatment. In recent years,...…
